Fexofenadine 60mg + Montelukast 4mg Suspension in PCD pharma franchise in Hyderabad

Fexofenadine 60mg + Montelukast 4mg Suspension in pharmaceutical manufacturing company in Mumbai

Fexofenadine 60mg + Montelukast 4mg Suspension in antiallergic pharma franchise in Pune

Fexofenadine 60mg + Montelukast 4mg Suspension in pharma suppliers in Delhi

Fexofenadine 60mg + Montelukast 4mg Suspension in pharma export companies in Kolkata
Fexofenadine 60mg + Montelukast 4mg Suspension in pharma franchise opportunities in Bengaluru

Home/Products /fexofenadine-hcl-i-point-p-60mg-montelukast-sodium-i-point-p-4mg-suspension

Monclip FX Suspension

Composition : Fexofenadine HCL I.P. 60mg + Montelukast Sodium I.P. 4mg

Dosage Form : Suspension

Packaging Type : with Measuring Cap

Packaging : 60ml

Price : ₹149/-

Monclip FX Suspension is a combination of Fexofenadine HCL I.P. (60mg) and Montelukast Sodium I.P. (4mg), formulated to provide effective relief from allergic rhinitis, seasonal allergies, and respiratory allergic conditions. Fexofenadine HCL, a non-sedating antihistamine, helps in blocking histamine action, thereby reducing symptoms like sneezing, itching, and runny nose. Montelukast Sodium, a leukotriene receptor antagonist (LTRA), works by preventing inflammation and allergic reactions, making it beneficial for asthma-related allergies and chronic urticaria. This combination ensures comprehensive allergy management with minimal drowsiness.

Read More

About the Product

Monclip FX Suspension is a combination of Fexofenadine HCL I.P. (60mg) and Montelukast Sodium I.P. (4mg), formulated to provide effective relief from allergic rhinitis, seasonal allergies, and respiratory allergic conditions. Fexofenadine HCL, a non-sedating antihistamine, helps in blocking histamine action, thereby reducing symptoms like sneezing, itching, and runny nose. Montelukast Sodium, a leukotriene receptor antagonist (LTRA), works by preventing inflammation and allergic reactions, making it beneficial for asthma-related allergies and chronic urticaria. This combination ensures comprehensive allergy management with minimal drowsiness.

Fexoform M Suspension is generally well-tolerated, but some patients may experience mild side effects such as headache, dizziness, dry mouth, nausea, or stomach discomfort. In rare cases, severe allergic reactions, increased heart rate, mood changes, or liver dysfunction may occur. If any severe symptoms appear, medical attention should be sought immediately.

This suspension is primarily indicated for the treatment of allergic rhinitis, hay fever, pollen allergies, and chronic urticaria (hives). It is also effective in managing respiratory allergies and preventing asthma-related allergic reactions. Additionally, it helps reduce nasal congestion, sneezing, and itchy or watery eyes caused by environmental allergens.

Shake well before use to ensure proper mixing of the suspension. It should be taken as prescribed by a healthcare professional, and the recommended dosage should not be exceeded. Avoid alcohol and sedatives while taking this medication, as they may enhance drowsiness. Patients with liver disease, kidney issues, or cardiovascular conditions should use this medication with caution. This suspension is not recommended for children under 2 years unless advised by a doctor.

Store Fexoform M Suspension at room temperature (below 30°C) in a dry place, away from direct sunlight and moisture. Keep the bottle tightly closed to prevent contamination and do not freeze the suspension. Ensure it is stored out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation